vs

Side-by-side financial comparison of FIRST INTERSTATE BANCSYSTEM INC (FIBK) and Kiniksa Pharmaceuticals International, plc (KNSA). Click either name above to swap in a different company.

FIRST INTERSTATE BANCSYSTEM INC is the larger business by last-quarter revenue ($313.0M vs $202.1M, roughly 1.5× Kiniksa Pharmaceuticals International, plc). FIRST INTERSTATE BANCSYSTEM INC runs the higher net margin — 34.8% vs 7.0%, a 27.7% gap on every dollar of revenue. On growth, Kiniksa Pharmaceuticals International, plc posted the faster year-over-year revenue change (65.0% vs 19.8%). Over the past eight quarters, Kiniksa Pharmaceuticals International, plc's revenue compounded faster (59.1% CAGR vs 13.7%).

First Interstate BancSystem, Inc. is a financial holding company headquartered in Billings, Montana. It is the parent company of First Interstate Bank, a community bank with locations throughout 14 states within the Western and Midwestern United States. It is the largest bank based in Montana, as measured by total assets.

Kiniksa Pharmaceuticals International plc is a global biopharmaceutical firm focused on discovering, developing and commercializing targeted therapies for patients with unmet medical needs, primarily in autoimmune, inflammatory and rare disease segments. It operates across major markets including North America, Europe and Asia, advancing a pipeline of clinical-stage and approved treatment candidates.

FIBK vs KNSA — Head-to-Head

Bigger by revenue
FIBK
FIBK
1.5× larger
FIBK
$313.0M
$202.1M
KNSA
Growing faster (revenue YoY)
KNSA
KNSA
+45.2% gap
KNSA
65.0%
19.8%
FIBK
Higher net margin
FIBK
FIBK
27.7% more per $
FIBK
34.8%
7.0%
KNSA
Faster 2-yr revenue CAGR
KNSA
KNSA
Annualised
KNSA
59.1%
13.7%
FIBK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FIBK
FIBK
KNSA
KNSA
Revenue
$313.0M
$202.1M
Net Profit
$108.8M
$14.2M
Gross Margin
89.6%
Operating Margin
44.5%
9.8%
Net Margin
34.8%
7.0%
Revenue YoY
19.8%
65.0%
Net Profit YoY
108.8%
259.8%
EPS (diluted)
$1.07
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FIBK
FIBK
KNSA
KNSA
Q4 25
$313.0M
$202.1M
Q3 25
$250.5M
$180.9M
Q2 25
$248.3M
$156.8M
Q1 25
$247.0M
$137.8M
Q4 24
$261.3M
$122.5M
Q3 24
$251.9M
$112.2M
Q2 24
$244.3M
$108.6M
Q1 24
$242.2M
$79.9M
Net Profit
FIBK
FIBK
KNSA
KNSA
Q4 25
$108.8M
$14.2M
Q3 25
$71.4M
$18.4M
Q2 25
$71.7M
$17.8M
Q1 25
$50.2M
$8.5M
Q4 24
$52.1M
$-8.9M
Q3 24
$55.5M
$-12.7M
Q2 24
$60.0M
$-3.9M
Q1 24
$58.4M
$-17.7M
Gross Margin
FIBK
FIBK
KNSA
KNSA
Q4 25
89.6%
Q3 25
88.8%
Q2 25
88.1%
Q1 25
87.0%
Q4 24
85.4%
Q3 24
82.1%
Q2 24
88.7%
Q1 24
86.7%
Operating Margin
FIBK
FIBK
KNSA
KNSA
Q4 25
44.5%
9.8%
Q3 25
37.0%
13.3%
Q2 25
37.7%
12.9%
Q1 25
26.9%
9.6%
Q4 24
25.5%
-15.7%
Q3 24
28.9%
-8.6%
Q2 24
32.1%
-0.1%
Q1 24
31.7%
-20.7%
Net Margin
FIBK
FIBK
KNSA
KNSA
Q4 25
34.8%
7.0%
Q3 25
28.5%
10.2%
Q2 25
28.9%
11.4%
Q1 25
20.3%
6.2%
Q4 24
19.9%
-7.3%
Q3 24
22.0%
-11.3%
Q2 24
24.6%
-3.6%
Q1 24
24.1%
-22.2%
EPS (diluted)
FIBK
FIBK
KNSA
KNSA
Q4 25
$1.07
$0.18
Q3 25
$0.69
$0.23
Q2 25
$0.69
$0.23
Q1 25
$0.49
$0.11
Q4 24
$0.50
$-0.11
Q3 24
$0.54
$-0.18
Q2 24
$0.58
$-0.06
Q1 24
$0.57
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FIBK
FIBK
KNSA
KNSA
Cash + ST InvestmentsLiquidity on hand
$414.1M
Total DebtLower is stronger
$146.3M
Stockholders' EquityBook value
$3.4B
$567.6M
Total Assets
$26.6B
$763.6M
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FIBK
FIBK
KNSA
KNSA
Q4 25
$414.1M
Q3 25
$352.1M
Q2 25
$307.8M
Q1 25
$268.3M
Q4 24
$243.6M
Q3 24
$223.8M
Q2 24
$218.8M
Q1 24
$213.6M
Total Debt
FIBK
FIBK
KNSA
KNSA
Q4 25
$146.3M
Q3 25
$146.2M
Q2 25
$252.0M
Q1 25
Q4 24
$132.2M
Q3 24
$137.3M
Q2 24
$383.4M
Q1 24
$370.8M
Stockholders' Equity
FIBK
FIBK
KNSA
KNSA
Q4 25
$3.4B
$567.6M
Q3 25
$3.4B
$535.4M
Q2 25
$3.4B
$495.0M
Q1 25
$3.4B
$457.5M
Q4 24
$3.3B
$438.4M
Q3 24
$3.4B
$437.0M
Q2 24
$3.2B
$435.1M
Q1 24
$3.2B
$431.9M
Total Assets
FIBK
FIBK
KNSA
KNSA
Q4 25
$26.6B
$763.6M
Q3 25
$27.3B
$712.3M
Q2 25
$27.6B
$661.1M
Q1 25
$28.3B
$599.3M
Q4 24
$29.1B
$580.6M
Q3 24
$29.6B
$555.3M
Q2 24
$30.3B
$542.4M
Q1 24
$30.1B
$519.7M
Debt / Equity
FIBK
FIBK
KNSA
KNSA
Q4 25
0.04×
Q3 25
0.04×
Q2 25
0.07×
Q1 25
Q4 24
0.04×
Q3 24
0.04×
Q2 24
0.12×
Q1 24
0.12×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FIBK
FIBK
KNSA
KNSA
Operating Cash FlowLast quarter
$305.6M
$53.9M
Free Cash FlowOCF − Capex
$53.3M
FCF MarginFCF / Revenue
26.4%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
2.81×
3.80×
TTM Free Cash FlowTrailing 4 quarters
$136.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FIBK
FIBK
KNSA
KNSA
Q4 25
$305.6M
$53.9M
Q3 25
$91.7M
$33.7M
Q2 25
$68.1M
$28.1M
Q1 25
$78.5M
$22.3M
Q4 24
$355.0M
$18.8M
Q3 24
$89.9M
$-2.2M
Q2 24
$82.3M
$5.2M
Q1 24
$87.6M
$4.0M
Free Cash Flow
FIBK
FIBK
KNSA
KNSA
Q4 25
$53.3M
Q3 25
$33.0M
Q2 25
$27.9M
Q1 25
$22.2M
Q4 24
$18.6M
Q3 24
Q2 24
Q1 24
$3.9M
FCF Margin
FIBK
FIBK
KNSA
KNSA
Q4 25
26.4%
Q3 25
18.2%
Q2 25
17.8%
Q1 25
16.1%
Q4 24
15.2%
Q3 24
Q2 24
Q1 24
4.9%
Capex Intensity
FIBK
FIBK
KNSA
KNSA
Q4 25
0.3%
Q3 25
0.4%
Q2 25
0.1%
Q1 25
0.1%
Q4 24
0.2%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.1%
Cash Conversion
FIBK
FIBK
KNSA
KNSA
Q4 25
2.81×
3.80×
Q3 25
1.28×
1.83×
Q2 25
0.95×
1.58×
Q1 25
1.56×
2.61×
Q4 24
6.81×
Q3 24
1.62×
Q2 24
1.37×
Q1 24
1.50×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons